AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Burford Capital Limited (BUR)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

15.46

-0.01 (-0.06%)

At close: Feb 20, 2025, 3:59 PM

15.47

0.06%

After-hours: Feb 20, 2025, 04:10 PM EST

undefined% (undefined)

Bid	15.09
Market Cap	3.39B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	1.9
PE Ratio (ttm)	8.14
Forward PE	n/a
Analyst	Buy

Ask	15.7
Volume	547,166
Avg. Volume (20D)	788,608
Open	15.37
Previous Close	15.47
Day's Range	15.29 - 15.50
52-Week Range	12.07 - 16.77
Beta	undefined

About BUR

Burford Capital Limited, through its subsidiaries, provides legal finance products and services. The company offers asset management services, including core legal finance, complex strategies, and post-settlement finance. The company was incorporated in 2009 and is based in Saint Peter Port, Guernsey....

[Show more]

Industry Asset Management

Sector Financial Services

IPO Date Oct 19, 2020

Employees 161

Stock Exchange NYSE

Ticker Symbol BUR

Website https://www.burfordcapital.com

Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for BUR stock is "Buy." The 12-month stock price forecast is $18, which is an increase of 16.43% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

6 months ago

-4.75%

Shares of companies within the broader financial s... Unlock content with Pro Subscription

11 months ago

+4.37%

Burford Capital shares are trading higher after the company reported better-than-expected FY23 financial results.

News

3 weeks ago · seekingalpha.com

Arbutus, Burford Capital, And Cadiz With Chris DeMuth Jr.

Chris DeMuth, Jr. shares some of his current top picks. Arbutus Biopharma is a promising investment due to its potential litigation value from IP claims against Pfizer and Moderna related to COVID-19 ...

2 months ago · zacks.com

Wall Street Analysts See a 45.49% Upside in Burford Capital (BUR): Can the Stock Really Move This High?

The consensus price target hints at a 45.5% upside potential for Burford Capital (BUR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings es...